Goserelin (Zoladex)

Goserelin is a type of hormone therapy used to treat breast cancer. Goserelin is the generic (non‑branded) name of the drug. Its current brand name is Zoladex.

It’s suitable for women whose breast cancer is sensitive to the female hormone oestrogen – known as oestrogen receptor positive or ER+ breast cancer.

Last reviewed: February 2015
Next planned review begins 2017

Let us know what you think

Please note that we cannot respond to comments. If you have any questions about breast cancer please contact the Helpline on 0808 800 6000.

Related Publication